Relay Therapeutics, Inc.

RLAY · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$124,287$143,736$998,917$280,119
Short-Term Investments$657,036$606,350$0$677,954
Receivables$0$0$5,219$4,940
Inventory$0$0$12,110$0
Other Curr. Assets$27,881$20,017$3,259$13,229
Total Curr. Assets$809,204$770,103$1,019,505$976,242
Property Plant & Equip (Net)$57,673$68,870$75,388$27,323
Goodwill$0$0$0$0
Intangibles$2,300$2,300$2,300$2,300
Long-Term Investments$0$2,707$2,578$0
Tax Assets$0$0-$2,578$0
Other NC Assets$2,119$0$2,578$2,578
Total NC Assets$62,092$73,877$80,266$32,201
Other Assets$0$0$0$0
Total Assets$871,296$843,980$1,099,771$1,008,443
Liabilities
Payables$14,097$9,211$10,578$8,276
Short-Term Debt$5,727$4,964$4,276$1,844
Tax Payable$0$0$0$0
Deferred Revenue$7,679$0$0$248
Other Curr. Liab.$23,226$16,094$48,855$13,953
Total Curr. Liab.$50,729$30,269$63,709$24,321
LT Debt$42,775$48,502$53,466$21,056
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$13,206$32,378$65,258
Total NC Liab.$42,775$61,708$85,844$86,314
Other Liabilities$0$0$0$0
Cap. Leases$48,502$53,466$57,742$22,900
Total Liabilities$93,504$91,977$149,553$110,635
Equity
Pref Stock$0$0$0$0
Common Stock$168$127$121$109
Retained Earnings-$1,738,290-$1,400,582-$1,058,609-$768,100
AOCI-$991-$196-$10,420-$1,088
Other Equity$2,516,905$2,152,654$2,019,126$1,666,887
Total Equity$777,792$752,003$950,218$897,808
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$871,296$843,980$1,099,771$1,008,443
Net Debt-$75,785-$90,270-$941,175-$257,219